Target intelligence / Profile preview

No discrete host molecular pharmacological target

Molecular classification
Other
01

Overview

The term "No discrete host molecular pharmacological target" refers to a classification for therapeutic agents that do not achieve their effect by binding to a specific host protein, such as a receptor, enzyme, or transporter (ChEMBL, 2024). Instead, these drugs operate through physicochemical processes, such as the chemical neutralization of gastric acid by antacids or the creation of osmotic gradients by agents like mannitol (Goodman & Gilman, 2023). This category also includes surfactants like simethicone and adsorbents like activated charcoal, which act through physical properties rather than molecular signaling (StatPearls, 2023). Because these agents lack a defined protein binding site, they do not follow standard pharmacological models of potency and affinity (IUPHAR/BGP, 2024). This designation is crucial for maintaining the integrity of drug-target databases by identifying compounds with non-specific mechanisms of action.

Other names
Non-molecular targetPhysicochemical mechanismNon-specific pharmacological action
02

Mechanism of action

Physicochemical interaction (e.g., neutralization, osmosis, adsorption)

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Electrolyte imbalanceMetabolic alkalosisInterference with drug absorptionOsmotic diarrhea
06

Interacting drugs

Magnesium hydroxide

7 more in the full profile.

Beyond the preview

Go deeper on No discrete host molecular pharmacological target.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on No discrete host molecular pharmacological target.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call